Example: Heart Attack

Search clinical trials for: Vincristine

Total 1075 results

NCT04448834

Not yet recruiting

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

Conditions: B-cell Acute Lymphoblastic Leukemia
NCT04446962

Not yet recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Conditions: Lymphoma, Large B-Cell, Diffuse; Central Nervous System Neoplasms, Primary
NCT04440267

Not yet recruiting

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Conditions: Acute Leukemia of Ambiguous Lineage
NCT04432714

Recruiting

Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

Conditions: DLBCL; Untreated; MYC Gene Rearrangement
NCT04423926

Recruiting

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Conditions: PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
NCT04402073

Not yet recruiting

Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma

Conditions: Medulloblastoma
NCT04393363

Not yet recruiting

Early Detection of Neuropathy and Cognitive Impairment Following Treatment for Haematological Malignancies

Conditions: Chemotherapy-induced Peripheral Neuropathy
NCT04388839

Not yet recruiting

Evolutionary Therapy for Rhabdomyosarcoma

Conditions: Rhabdomyosarcoma
NCT04361279

Recruiting

A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL

Conditions: Diffuse Large B-Cell Lymphoma
NCT04332822

Not yet recruiting

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Conditions: DLBCL; Diffuse Large B Cell Lymphoma
NCT04323956

Recruiting

Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma

Conditions: Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma
NCT04322318

Not yet recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Conditions: Anaplastic Kidney Wilms Tumor; Recurrent Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor
NCT04308330

Recruiting

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Conditions: Ewing Sarcoma; Rhabdomyosarcoma; Wilms Tumor; Neuroblastoma; Hepatoblastoma; Germ Cell Tumor
NCT04307576

Recruiting

A Treatment Study Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia

Conditions: Leukemia, Acute Lymphoblastic
NCT04301076

Not yet recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)

Conditions: Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection
NCT04263584

Not yet recruiting

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

Conditions: Diffuse Large B Cell Lymphoma
NCT04243434

Not yet recruiting

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Conditions: Hematologic Diseases
NCT04231448

Recruiting

Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL

Conditions: Diffuse Large B-cell Lymphoma
NCT04221035

Recruiting

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Conditions: High-Risk Neuroblastoma
NCT04214626

Recruiting

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Conditions: Diffuse Large B Cell Lymphoma
NCT04216524

Recruiting

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm
NCT04213612

Not yet recruiting

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Conditions: Unrecognized Condition
NCT04199026

Not yet recruiting

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Conditions: Metastatic Sarcoma; Recurrent Sarcoma; Resectable Sarcoma
NCT04181489

Recruiting

Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS

Conditions: EBV-Positive DLBCL, Nos
NCT04166409

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Conditions: Astrocytoma; Low Grade Glioma
NCT04164368

Recruiting

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

Conditions: Double Expressor Lymphoma
NCT04152577

Recruiting

R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL

Conditions: Lymphoma, B-Cell
NCT04139304

Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Conditions: Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Plasmablastic Lymphoma
NCT04134247

Not yet recruiting

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Conditions: Relapsed/Refractory Non-Hodgkin's Lymphoma
NCT04067037

Recruiting

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Conditions: Classical Hodgkin Lymphoma
NCT04058470

Recruiting

Toripalimab in Combination With R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

Conditions: Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Follicular Lymphoma Grade IIIb; Transformed Lymphoma; EBV-Positive DLBCL, Nos; ALK-Positive Anaplastic Large Cell Lymphoma
NCT04043494

Recruiting

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

Conditions: Lymphoblastic Lymphoma, Childhood
NCT04025593

Recruiting

Biomarker Guided Treatment in DLBCL

Conditions: Diffuse Large B Cell Lymphoma
NCT04023916

Not yet recruiting

Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma.

Conditions: Diffuse Large B-Cell Lymphoma; Sintilimab; TP53 Mutation
NCT04022980

Recruiting

R-MPV Followed by Nivolumab in Older (≥65) Pts With Previously Untreated Primary CNS Lymphoma

Conditions: Brain and Nervous System; Eye and Orbit
NCT04002947

Recruiting

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Conditions: Diffuse Large B-Cell Lymphoma; Non Hodgkin's Lymphoma; DLBCL; NHL
NCT03997981

Recruiting

Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)

Conditions: Chemotherapy-induced Peripheral Neuropathy
NCT03995147

Recruiting

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Conditions: B Cell Lymphoma; Lymphoma; Lymphoma, B-Cell; Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma
NCT03991884

Recruiting

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Conditions: Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
NCT03986463

Recruiting

CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility

Conditions: Lung Neoplasms; Lung Cancer; Neoplasm of Lung; Non Small Cell Lung Cancer
NCT03984448

Recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Conditions: Diffuse Large B-Cell Lymphoma; Double-Expressor Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present
NCT03981510

Recruiting

Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation

Conditions: Constipation; Childhood Acute Lymphoblastic Leukemia; Neurofibromatosis 1; Chronic Constipation With Overflow
NCT03962465

Recruiting

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL

Conditions: B-cell Acute Lymphoblastic Leukemia
NCT03959085

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Conditions: B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Central Nervous System Leukemia; Mixed Phenotype Acute Leukemia; Testicular Leukemia
NCT03952572

Recruiting

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT03943901

Not yet recruiting

Split-Dose R-CHOP for Older Adults With DLBCL

Conditions: Diffuse Large B Cell Lymphoma; DLBCL; Cancer
NCT03931642

Recruiting

BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation

Conditions: Richter Syndrome
NCT03914625

Recruiting

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Conditions: B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Down Syndrome
NCT03909464

Completed

Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy

Conditions: Cancer; Malignancy; Malignant Neoplasm; Neuropathy; Neuropathies Sensory; Chemotherapy-induced Peripheral Neuropathy
NCT03899337

Not yet recruiting

A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

Conditions: Richter Syndrome